Comparison between Glenmark Life Sciences IPO and Zomato IPO.
Glenmark Life Sciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Zomato IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Zomato IPO is up to ₹9,375.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Zomato IPO is ₹76.00 per share.
| Glenmark Life Sciences IPO | Zomato IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹695.00 per share | ₹72.00 per share |
| Issue Price (Upper) | ₹720.00 per share | ₹76.00 per share |
| Issue Price (Final) | ₹720.00 per share | ₹76.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 20 shares | 195 shares |
| Fresh Issue Size | 1,47,22,222 shares | 1,18,42,10,526 shares |
| Fresh Issue Size (Amount) | up to ₹1,060.00 Cr | up to ₹9,000.00 Cr |
| OFS Issue Size | 63,00,000 shares | 4,93,42,105 shares |
| OFS Issue Size (Amount) | up to ₹453.60 Cr | up to ₹375.00 Cr |
| Issue Size Total | 2,10,22,222 shares | 1,23,35,52,631 shares |
| Issue Size Total (Amount) | up to ₹1,513.60 Cr | up to ₹9,375.00 Cr |
Glenmark Life Sciences IPO opens on Jul 27, 2021, while Zomato IPO opens on Jul 14, 2021. The closing date of Glenmark Life Sciences IPO and Zomato IPO is Jul 29, 2021, and Jul 16, 2021, respectively.
| Glenmark Life Sciences IPO | Zomato IPO | |
|---|---|---|
| Anchor Bid Date | Jul 26, 2021 | Jul 13, 2021 |
| Issue Open | Jul 27, 2021 | Jul 14, 2021 |
| Issue Close | Jul 29, 2021 | Jul 16, 2021 |
| Basis Of Allotment (Tentative) | Aug 03, 2021 | Jul 22, 2021 |
| Initiation of Refunds (Tentative) | Aug 04, 2021 | Jul 23, 2021 |
| Credit of Share (Tentative) | Aug 05, 2021 | Jul 23, 2021 |
| Listing date (Tentative) | Aug 06, 2021 | Jul 23, 2021 |
| Anchor Lockin End date 1 | Sep 02, 2021 | Aug 21, 2021 |
| Anchor Lockin End date 2 | Nov 01, 2021 | Oct 20, 2021 |
Glenmark Life Sciences IPO P/E ratio is , as compared to Zomato IPO P/E ratio of .
| Glenmark Life Sciences IPO | Zomato IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | |||||
| Promoter Shareholding (Post-Issue) | 82.84 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹8821.96 Cr. | ₹59623.37 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Glenmark Life Sciences IPO Retail Individual Investors (RII) are offered 73,57,778 shares while in Zomato IPO retail investors are offered 73,57,778 shares. Qualified Institutional Buyers (QIB) are offered 42,04,450 shares in Glenmark Life Sciences IPO and 36,81,15,969 shares in Zomato IPO.
| Glenmark Life Sciences IPO | Zomato IPO | |
|---|---|---|
| Anchor Investor Reservation | 63,06,660 shares | 55,21,73,505 shares |
| Market Maker Reservation | ||
| QIB | 42,04,450 shares | 36,81,15,969 shares |
| NII | 31,53,334 shares | 18,40,57,894 shares |
| RII | 73,57,778 shares | 12,27,05,263 shares |
| Employee | 65,00,000 shares | |
| Others | ||
| Total | 2,10,22,222 shares | 1,23,35,52,631 shares |
Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Zomato IPO subscribed 38.25x.
| Glenmark Life Sciences IPO | Zomato IPO | |
|---|---|---|
| QIB (times) | 36.97x | 51.79x |
| NII (times) | 122.54x | 32.96x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 14.63x | 7.45x |
| Employee (times) | 0.62x | |
| Other (times) | ||
| Total (times) | 44.17x | 38.25x |
